Based in Boston, Massachusetts, Inspired Health is a healthcare insights and intelligence consultancy. Using innovative market research techniques, Inspired Health assists its life science clients to better understand physicians, patients, administrators, and payers. These insights are leveraged to optimise clients’ product innovation and commercialise their assets. High quality research and insights are the foundation to a successful commercialisation strategy. Inspired Health will be integrated into Uniphar’s Commercial & Clinical division and its market research expertise will enable Uniphar to evolve its commercialisation offering and enhance client competitiveness. The acquisition increases Uniphar’s presence in the strategically important US market and Inspired Health complements its recent US acquisitions of BESTMSLs, Diligent Health Solutions and RRD International.
Ger Rabbette, CEO of Uniphar commented:
“The acquisition of Inspired Health adds another vital component to our high value commercialisation offering and further increases our scale in the world’s largest healthcare market. Market research is the first step on the journey towards successful commercialisation and the insights gained from Inspired Health’s innovative service offering will be leveraged across the Group. We are excited to welcome the highly innovative Inspired Health team to the Group.”
Kieron Mathews and Andrew Wilson, Joint Managing Directors of Inspired Health commented:
“Inspired Health has been on an incredible journey over the last number of years and today marks a significant milestone for the team. The Uniphar Group recognise the important role insights, data and market research play across an asset’s lifecycle and as such is an ideal home for Inspired Health. Uniphar have built a compelling commercial offering to date, and we look forward to adding to that through our innovative solutions. Having previously worked with Green Square, it was a pleasure to partner with them again, achieve another successful outcome and we will appreciate their continued support throughout the journey.”
Liam Logue, President of Uniphar USA commented:
“Inspired Health has a reputation as one of the fastest growing innovators in the healthcare insights and intelligence sector. I am excited to bring the Inspired team into the Uniphar group, and leverage its skills to enhance our offerings to support life science innovation and commercialisation.”
Andrew Moss, Partner, Green Square commented:
“We have known the Inspired team since 2014 when we completed a previous transaction in which they were involved. They subsequently went on to start and build Inspired Health, which we have been delighted to bring together with Uniphar plc. Having had numerous offers, Uniphar was the best strategic fit and represents the next step they were looking for. It will be an exciting journey that will allow them and their clients to take advantage of a much larger Group that is strongly developing its life science innovation and commercialisation offer. We wish them all the very best and will stay close, as always.”
A slide from suitor Next 15’s investor presentationNext 15 Next 15 said it would offer complementary client bases, an “enhanced” public sector offering and clearer focus on data and analytics. It would also invest across EMEA and APAC, as well as strengthen eCommerce, paid media, demand/lead generation and strategic consulting services. Unlike AdvT, which during the last AGM voted against the reappointment of Gareth Davis and non-executive Lisa Gordon as directors, Next 15 has placed “great importance” on retaining existing management and employees—and revealed that it had already held some initial “high level” planning and post-merger discussions. The future business would be led by a team featuring key people from both Next 15 and M&C Saatchi, the investor proposal revealed. Stalling the outcome But in June, another wrench was thrown into the deal. M&C Saatchi directors argued the deal shouldn’t go forward. “The M&C Saatchi Directors, who have been so advised by Numis and Liberum as to the financial terms of the Next 15 Offer, no longer consider the terms of the Next 15 Offer to be fair and reasonable solely on the basis of the deterioration in value of Next 15 Shares since the Announcement Date.” “We reached agreement with the board and executive team of M&C Saatchi after extensive negotiation and believe our offer is full and fair,” said Next 15 CEO Tim Dyson. “We do not believe that the recent market volatility undermines the fundamental proposition of this transaction.” “We are focused on our very successful strategy of delivering meaningful change for our clients—and accelerating our journey of simplification, digitization and connection.” Moray MacLennan, chief executive officer for M&C Saatchi The two parties were then set to meet August 19 to vote on the bid. But following M&C’s strong half-year results and the tumble in Next 15 shares, another disparity emerged. M&C Saatchi reported a 10% growth in revenue year-on-year with an anticipated pre-tax profit of around $37.5 million (31 million pounds) by the end of 2022. The better-than-expected results are anticipated to continue through 2022, with heightened demand for M&C’s specialist services in the U.K., Americas and Asia. “We are focused on our very successful strategy of delivering meaningful change for our clients and accelerating our journey of simplification, digitization and connection,” Moray MacLennan, chief executive officer for M&C Saatchi, told Adweek. “Our recent client wins, including PepsiCo, Barclays, and Samsung, reflect the strength of our approach. We remain confident that we will continue on this trajectory.” So that leaves three potential outcomes: AdvT wins. Next 15 wins. Or M&C Saatchi remains independent. “I suspect Murria wanted to get it cheap, shift out the old guard and bring new people in, reorganize, make some acquisitions and then flip it on or potentially list it again,” explained Barry Dudley, a partner at media and marketing consultancy Green Square. “Meanwhile, Next 15 sees it as a business that is performing very well, that perhaps needs a little help to take it forward—but wants to largely keep it going with the plans existing management have in place.” So, more time is added to the clock.